by MM360 Staff | Mar 20, 2026 | Uncategorized
Source: CURE articles Post Content Read More
by MM360 Staff | Mar 16, 2026 | Uncategorized
Source: CURE articles Post Content Read More
by Matthew Shinkle | Mar 6, 2026 | Uncategorized
The FDA has approved teclistamab-cqyv in combination with daratumumab hyaluronidase-fihj for adults with relapsed or refractory multiple myeloma who received at least one prior line of therapy.As the third approval under the Commissioner’s National Priority Voucher...
by MM360 Staff | Mar 4, 2026 | Uncategorized
Source: CURE articles Post Content Read More
by MM360 Staff | Mar 2, 2026 | Uncategorized
Source: CURE articles Post Content Read More
by MM360 Staff | Feb 27, 2026 | Uncategorized
Source: CURE articles Post Content Read More